We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

125 hedge funds and large institutions have $133M invested in Voyager Therapeutics in 2025 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 45 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

786% more call options, than puts

Call options by funds: $567K | Put options by funds: $64K

138% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 8

7% more funds holding

Funds holding: 117 → 125 (+8)

6.22% more ownership

Funds ownership: 54.47% → 60.69% (+6.2%)

6% less capital invested

Capital invested by funds: $141M → $133M (-$8.48M)

31% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 45

Holders
125
Holders Change
+8
Holders Change %
+6.84%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
31
Reduced
45
Closed
8
Calls
$567K
Puts
$64K
Net Calls
+$503K
Net Calls Change
-$470K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$14.7M
2
OM
Opaleye Management
Massachusetts
+$5.29M
3
AS
Altshuler Shaham
Israel
+$901K
4
Citadel Advisors
Citadel Advisors
Florida
+$701K
5
SFM
Sphera Funds Management
Israel
+$619K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.82M
2
Bank of America
Bank of America
North Carolina
-$1.11M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.07M
4
UBS Group
UBS Group
Switzerland
-$904K
5
AC
Armistice Capital
New York
-$885K
Name Holding Trade Value Shares
Change 		Change in
Stake
VCM
101
Versant Capital Management
Arizona
$4K +$4.51K +1,019 New
HPC
102
HM Payson & Co
Maine
$3.93K -$2.21K -500 -33%
Rockefeller Capital Management
103
Rockefeller Capital Management
New York
$3.57K +$703 +159 +21%
PNC Financial Services Group
104
PNC Financial Services Group
Pennsylvania
$3.22K -$2.79K -632 -44%
TC
105
Truvestments Capital
Florida
$3.17K -$4 -1 -0.1%
FDCDDQ
106
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.78K +$3.14K +709 New
Optiver Holding
107
Optiver Holding
Netherlands
$2.51K – – –
CA
108
CoreCap Advisors
Michigan
$2.16K – – –
Nisa Investment Advisors
109
Nisa Investment Advisors
Missouri
$1.72K – – –
SPIA
110
Steward Partners Investment Advisory
New York
$1.57K – – –
AAP
111
Arax Advisory Partners
Colorado
$1.46K -$5.54K -1,253 -77%
TWD
112
True Wealth Design
Ohio
$1.44K +$4 +1 +0.3%
FFA
113
Farther Finance Advisors
California
$1.4K – – –
EWA
114
EverSource Wealth Advisors
Alabama
$1.12K – – –
EP
115
Essential Partners
California
$1.08K +$18 +4 +1%
Daiwa Securities Group
116
Daiwa Securities Group
Japan
$1K – – –
Jones Financial Companies
117
Jones Financial Companies
Missouri
$904 – – –
CFD
118
Creative Financial Designs
Indiana
$786 – – –
PMIM
119
Prudent Man Investment Management
Colorado
$688 – – –
AF
120
Allworth Financial
California
$645 – – –
BWA
121
Basecamp Wealth Advisors
Washington
$554 +$624 +141 New
SS
122
Sunbelt Securities
Texas
$141 – – –
IA
123
IFP Advisors
Florida
$141 +$102 +23 +177%
Northwestern Mutual Wealth Management
124
Northwestern Mutual Wealth Management
Wisconsin
$110 +$124 +28 New
GCP
125
GSA Capital Partners
United Kingdom
– -$860K -184,203 Closed
2 3 4
5
6

VYGR Hedge Fund Activity: Q4 2025 in Review

125 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q4 2025, worth a combined $133M — down 6% from $141M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new VYGR positions and 8 closed out — a net gain of 11 holders — while 31 added to existing stakes and 45 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $14.7M. The largest seller was Millennium Management, cutting an estimated $1.82M.

  • 125 institutional investors held Voyager Therapeutics (VYGR) as of Q4 2025, up from 117 in Q3 2025.
  • Funds reported $133M of Voyager Therapeutics stock for Q4 2025, down 6% quarter-over-quarter.
  • 19 funds opened new Voyager Therapeutics positions in Q4 2025 and 8 closed out, a net change of +11 holders.
  • The largest Voyager Therapeutics buyer in Q4 2025 was EcoR1 Capital, an estimated $14.7M added.
  • The largest Voyager Therapeutics seller in Q4 2025 was Millennium Management, an estimated $1.82M sold.

Based on aggregated 13F filings for Q4 2025.